Sort
48,018 grants matching “immunotherapy”
Combining AD Epitope Vaccine with Innate Immunity
$433,515David Hastings Cribbs · University Of California-Irvine · R01 · FY2012 · NS
Role of CHI3L1 in accelerating breast cancer metastasis: a mechanistic approach
$433,500Vijaya L Iragavarapu-Charyulu · Florida Atlantic University · R15 · FY2012 · CA
Modulation of Mcl-1 for Treatment of Lung Cancer
$433,488Xingming Deng · Emory University · R01 · FY2021 · CA
Study of Interleukin 33 as a new immunotherapy of lung cancer
$433,485Binfeng Lu · Hackensack University Medical Center · R01 · FY2023 · CA
Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface
$433,439Melody A Swartz · University Of Chicago · R01 · FY2021 · CA
Mechanistic studies of anti-tau antibodies effects on tau biochemistry
$433,433Colin G Wu · Oakland University · R15 · FY2016 · GM
Protecting Pancreatic Islet Grafts from Rejection
$433,415Isogenis, Inc. · R43 · FY2004 · DK
Chemotherapy plus vaccine for metastatic breast cancer
$433,408Johns Hopkins University · R01 · FY2003 · CA
Project 3: Identifying Targetable Epigenetic and Immuno-Oncologic Vulnerabilities in Synovial Sarcoma
$433,378Marc Ladanyi · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Project 3: Chemokine modulation in TME for enhanced TLS formation and cross-priming/ recruitment of therapeutic CD8+ TILs
$433,366Walter J Storkus · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA
MECHANISMS OF MURINE TUMOR ERADICATION BY IMMUNOTHERAPY
$433,354University Of Washington · R37 · FY2000 · CA
Mcl-1/Bfl-1 in apoptosis and signal transduction: a structure/function approach
$433,304Maurizio Pellecchia · University Of California Riverside · R01 · FY2020 · CA
Mcl-1/Bfl-1 in apoptosis and signal transduction: a structure/function approach
$433,304Maurizio Pellecchia · University Of California Riverside · R01 · FY2021 · CA
Lung Cancer Vaccine
$433,293Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · U54 · FY2024 · CA
INHIBITION OF NEUROPILIN-2 TO ENHANCE IMMUNOTHERAPY OF LETHAL PROSTATE CANCER
$433,258University Of Massachusetts Medical School · · FY2021 · Defense Health Agency
Targeting a PHGDH metabolic vulnerability in melanoma
$433,256Florian Karreth · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2024 · CA
A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome
$433,229Arvind P Pathak · Johns Hopkins University · R01 · FY2021 · CA
Development of mosaic enterovirus mRNA vaccine to prevent hand, foot and mouth disease
$433,175Todd Christopher Bradley · Children'S Mercy Hosp (Kansas City, Mo) · R21 · FY2025 · AI
Role of histotripsy synergized CD40 signaling in the re-engineering of cold tumors
$433,173Ashish Ranjan · Oklahoma State University Stillwater · R01 · FY2022 · CA
Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
$433,154Changchun Xiao · Scripps Research Institute, The · R01 · FY2019 · AI
Heterlogous Prime and Boost Vaccine Strategies
$433,149Duke University · P01 · FY2005 · CA
Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy
$433,138Wei Wei · Institute For Systems Biology · R33 · FY2022 · CA
Peripheral Adaptive Immune System Changes Associated with Alzhiemer's Disease
$433,126Naresha Saligrama · Washington University · R21 · FY2021 · AG
Post-transplant vaccines to enhance graft-versus-leukemia responses
$433,125Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2012 · HL
Inhibiting Corneal Neovascularization by Targeting Tissue Factor
$433,125Hua Zhu · Ohio State University · R21 · FY2025 · EY